Details for New Drug Application (NDA): 016769
✉ Email this page to a colleague
NDA 016769 describes URISPAS, which is a drug marketed by Ortho Mcneil Janssen and is included in one NDA. Additional details are available on the URISPAS profile page.
The generic ingredient in URISPAS is flavoxate hydrochloride. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the flavoxate hydrochloride profile page.
The generic ingredient in URISPAS is flavoxate hydrochloride. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the flavoxate hydrochloride profile page.
Summary for 016769
| Tradename: | URISPAS |
| Applicant: | Ortho Mcneil Janssen |
| Ingredient: | flavoxate hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016769
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
